arrow
J

Javier De Las Rivas

university of salamanca
H指数:58
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deletion of 9p drives B-ALL through heterozygous inactivation of Pax5 and Cd72 in preleukemic cells

通过Pax5和Cd72的杂合失活在白血病前体细胞中驱动B-ALL的9p缺失

2026-04-080
OA
Experimental assessment of AI-based interactome mapping

基于人工智能的互作组图谱构建的实验评估

2026-04-040
OAAI
Challenges in the preclinical design and assessment of CAR-T cells

CAR-T细胞临床前设计与评估中的挑战

2025-08-080
OA
Humoral Response Profile in SARS-CoV-2 Infection: Differences across Virus Strains and Influenza

SARS-CoV-2感染中的体液应答特征:不同病毒株与流感间的差异

2025-07-010
PRE
Tonic signaling of the B-cell antigen-specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

B细胞抗原特异性受体的基础信号是其早期疾病阶段慢性淋巴细胞白血病细胞磷酸化蛋白质组中的一个共同功能特征。

2025-03-250
OAAI
Assessment of Humoral Response at SARS-CoV-2 Infection by Multipronged Functional Proteomics Approaches

通过多管齐下的功能蛋白质组学方法评估SARS-CoV-2感染时的体液反应

2025-01-070
PRE
Genetic variability in proteoglycan biosynthetic genes reveals new facets of heparan sulfate diversity
2024-12-010
OAAI
Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice
2023-08-246
OAAI
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

METTL1通过tRNA衍生的片段生物发生促进前列腺癌的发生

2023-07-2929
OAAI
Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
2022-09-288
OAAI
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
2022-03-1511
OAAI
SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS

SARS-CoV-2感染引发ARDS的自身免疫反应

2022-01-2818
OAAI
Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients

癌症相关的成纤维细胞衍生的基因特征决定了结肠癌患者的预后

2021-04-2959
OAAI